1. Home
  2. EQNR vs BSX Comparison

EQNR vs BSX Comparison

Compare EQNR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equinor ASA

EQNR

Equinor ASA

HOLD

Current Price

$39.63

Market Cap

96.0B

Sector

Energy

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$55.97

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQNR
BSX
Founded
1972
1979
Country
Norway
United States
Employees
24140
N/A
Industry
Integrated oil Companies
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.0B
93.4B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
EQNR
BSX
Price
$39.63
$55.97
Analyst Decision
Hold
Strong Buy
Analyst Count
4
22
Target Price
$37.00
$93.18
AVG Volume (30 Days)
3.8M
18.3M
Earning Date
05-06-2026
04-22-2026
Dividend Yield
3.08%
N/A
EPS Growth
N/A
55.20
EPS
N/A
0.90
Revenue
N/A
$9,076,000,000.00
Revenue This Year
$13.35
$11.85
Revenue Next Year
N/A
$10.16
P/E Ratio
$14.56
$58.68
Revenue Growth
N/A
12.49
52 Week Low
$22.26
$52.52
52 Week High
$43.46
$109.50

Technical Indicators

Market Signals
Indicator
EQNR
BSX
Relative Strength Index (RSI) 54.89 42.84
Support Level $23.15 N/A
Resistance Level $41.88 $58.18
Average True Range (ATR) 1.00 1.60
MACD -0.02 0.13
Stochastic Oscillator 63.18 60.95

Price Performance

Historical Comparison
EQNR
BSX

About EQNR Equinor ASA

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2025 (50% liquids) and ended 2025 with 5.2 billion barrels of proven reserves (45% liquids). Operations also include oil refineries and natural gas processing, marketing, and trading. The renewables portfolio includes offshore and onshore wind and solar, with total power generation of 5.65 TWh in 2025.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: